An advisory committee to the Food and Drug Administration voted yesterday to recommend that compounding pharmacies be allowed to make the peptide, even though it has little human-safety data and hasnt passed through the normal FDA drug-approval process
Alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation
The modest impact of transcription factor Nrf2 on the course of disease in an ALS animal model
About this article Cite this article Tripathi, A.K., Ray, A.K., Mishra, S.K
Possible Mild Reactions Redness Itching Minor irritation at the application site These are generally transient and resolve on their own
Rarely, mild nausea (more commonly discussed when administered on an empty stomach in some protocols)